"The recent FDA-approval of liraglutide presents a safe option to pediatric endocrinologists to avoid weight gain while effectively managing glycemic control," explains alumna Megan Oberle. Her study proposes this treatment for Type 2 Diabetes. Read more:
717 followers
592 followers
RT @VernDolinsky: Is it time to consider Glucagon-Like Peptide-1 Receptor Agonists for the treatment of Type 2 #Diabetes in #Youth? https:/…
865 followers
Is it time to consider Glucagon-Like Peptide-1 Receptor Agonists for the treatment of Type 2 #Diabetes in #Youth? https://t.co/2zsx9Bo7xu
4,806 followers
New Research: It Is Time to Consider Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Type 2 Diabetes in Youth https://t.co/MQ1hOWKZCq #Endocrinology #Endo